FDA Warns CR Bard Over 'Adulterated' Med. Devices

Law360, New York (October 14, 2008, 12:00 AM EDT) -- A U.S. Food and Drug Administration inspection of a Puerto Rico plant of medical device maker C.R. Bard Inc. revealed a slew of manufacturing problems, the agency revealed in a letter made public Tuesday.

FDA inspectors who visited the company's plant in Humacao, Puerto Rico, between November 2007 and February 2008 found that gastroenterological, cardiovascular and surgical medical devices manufactured there were “adulterated,” according to the letter, which was sent in July.

Manufacturing and storing methods at the plant were not in conformity with the Current...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.